|
IL79289A
(en)
|
1985-07-05 |
1992-01-15 |
Whitehead Biomedical Inst |
Introduction and expression of foreign genetic material into keratinocytes using a recombinant retrovirus
|
|
US4980286A
(en)
|
1985-07-05 |
1990-12-25 |
Whitehead Institute For Biomedical Research |
In vivo introduction and expression of foreign genetic material in epithelial cells
|
|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
|
ATE117375T1
(de)
|
1987-09-11 |
1995-02-15 |
Whitehead Biomedical Inst |
Transduktionsveränderte fibroblasten und ihre anwendung.
|
|
JP2914692B2
(ja)
|
1987-12-11 |
1999-07-05 |
ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ |
内皮細胞の遺伝子修飾
|
|
WO1989007136A2
(en)
|
1988-02-05 |
1989-08-10 |
Whitehead Institute For Biomedical Research |
Modified hepatocytes and uses therefor
|
|
US6905680B2
(en)
|
1988-11-23 |
2005-06-14 |
Genetics Institute, Inc. |
Methods of treating HIV infected subjects
|
|
US5858358A
(en)
|
1992-04-07 |
1999-01-12 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for selectively stimulating proliferation of T cells
|
|
US6534055B1
(en)
|
1988-11-23 |
2003-03-18 |
Genetics Institute, Inc. |
Methods for selectively stimulating proliferation of T cells
|
|
US6352694B1
(en)
|
1994-06-03 |
2002-03-05 |
Genetics Institute, Inc. |
Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
|
|
ES2096750T3
(es)
|
1990-10-31 |
1997-03-16 |
Somatix Therapy Corp |
Vectores retroviricos utiles para la terapia genica.
|
|
US7175843B2
(en)
|
1994-06-03 |
2007-02-13 |
Genetics Institute, Llc |
Methods for selectively stimulating proliferation of T cells
|
|
US5827642A
(en)
|
1994-08-31 |
1998-10-27 |
Fred Hutchinson Cancer Research Center |
Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
|
|
US6692964B1
(en)
|
1995-05-04 |
2004-02-17 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for transfecting T cells
|
|
US7067318B2
(en)
|
1995-06-07 |
2006-06-27 |
The Regents Of The University Of Michigan |
Methods for transfecting T cells
|
|
AU2605600A
(en)
*
|
1999-01-11 |
2000-08-01 |
Mindset Biopharmaceuticals (Usa) Inc. |
Methods for regulating the stability of recombinant proteins and products usefultherein
|
|
CA2361292C
(en)
*
|
1999-03-16 |
2012-05-29 |
Edward A. Berger |
A novel chimeric protein for prevention and treatment of hiv infection
|
|
AU5275100A
(en)
*
|
1999-05-21 |
2000-12-12 |
Regents Of The University Of California, The |
Fluorescent protein indicators
|
|
AU6094100A
(en)
*
|
1999-07-13 |
2001-01-30 |
Heska Corporation |
Fc epsilon receptor-luminescence inducing protein chimeric nucleic acid molecules, fusion proteins and uses thereof
|
|
KR20030032922A
(ko)
|
2000-02-24 |
2003-04-26 |
싸이트 테라피스 인코포레이티드 |
세포의 동시 자극 및 농축
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
US6797514B2
(en)
|
2000-02-24 |
2004-09-28 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
US6867041B2
(en)
|
2000-02-24 |
2005-03-15 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
US20030170238A1
(en)
|
2002-03-07 |
2003-09-11 |
Gruenberg Micheal L. |
Re-activated T-cells for adoptive immunotherapy
|
|
US7446190B2
(en)
*
|
2002-05-28 |
2008-11-04 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acids encoding chimeric T cell receptors
|
|
JP5276846B2
(ja)
|
2005-09-13 |
2013-08-28 |
国立大学法人三重大学 |
Ｔ細胞レセプターをコードする核酸が挿入されてなるベクター及び該レセプターを発現する細胞
|
|
JP5307708B2
(ja)
|
2006-06-02 |
2013-10-02 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
ヒトｉｌ−６受容体に対する高親和性抗体
|
|
PH12013501201A1
(en)
*
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
US9987308B2
(en)
|
2011-03-23 |
2018-06-05 |
Fred Hutchinson Cancer Research Center |
Method and compositions for cellular immunotherapy
|
|
WO2013044225A1
(en)
*
|
2011-09-22 |
2013-03-28 |
The Trustees Of The University Of Pennsylvania |
A universal immune receptor expressed by t cells for the targeting of diverse and multiple antigens
|
|
EP3559049B1
(en)
|
2011-10-28 |
2025-06-11 |
Teva Pharmaceuticals Australia Pty Ltd |
Polypeptide constructs and uses thereof
|
|
BR112014029417B1
(pt)
|
2012-05-25 |
2023-03-07 |
Cellectis |
Método ex vivo para a preparação de células t para imunoterapia
|
|
BR112017005631A2
(pt)
*
|
2014-09-19 |
2018-06-26 |
City Of Hope |
células t com receptor de antígeno coestimulador quimérico direcionadas à il13ra2
|
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
|
AU2016306209B2
(en)
*
|
2015-08-07 |
2023-07-06 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Bispecific CAR T-cells for solid tumor targeting
|
|
GB201604458D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against cancers
|
|
DK3440106T3
(da)
|
2016-04-08 |
2021-10-04 |
Adaptimmune Ltd |
T-cellereceptorer
|
|
US20190310250A1
(en)
*
|
2016-12-16 |
2019-10-10 |
Merck Patent Gmbh |
Methods for the use of galectin 3 binding protein detected in the urine for monitoring the severity and progression of lupus nephritis
|
|
WO2018225732A1
(ja)
|
2017-06-05 |
2018-12-13 |
国立大学法人三重大学 |
Ｍａｇｅ－ａ４由来ペプチドを認識する抗原結合性タンパク質
|
|
US20210388100A1
(en)
*
|
2018-10-01 |
2021-12-16 |
Adicet Bio, Inc. |
Compositions and methods regarding engineered and non-engineered gamma delta t-cells for treatment of hematological tumors
|
|
EP4004049A1
(en)
*
|
2019-07-24 |
2022-06-01 |
Regeneron Pharmaceuticals, Inc. |
Chimeric antigen receptors with mage-a4 specificity and uses thereof
|
|
US12077603B2
(en)
|
2019-08-15 |
2024-09-03 |
Regeneron Pharmaceuticals, Inc. |
Multispecific antigen-binding molecules for cell targeting and uses thereof
|
|
KR20230025662A
(ko)
*
|
2020-05-05 |
2023-02-22 |
리제너론 파마슈티칼스 인코포레이티드 |
Cd28 제타 및 cd3 제타를 포함하는 car
|